Contact Person

SeSaM-Biotech
Mr.
David
Schönauer
CEO
+49 241 938 569 79

News

Lessons from diversity of directed evolution experiments by an analysis of 3,000 mutations.
14 July 2014
Zhao J, Kardashliev T, Joelle
Biotechnol Bioeng 2014
Diversity generation by random mutagenesis is often the first key step in directed evolution...
read more >>
Bacillus gibsonii alkaline protease
1 November 2012
Martinez R, Jakob F, Tu R, Sie
Biotechnol Bioeng. 2013 Mar
Bacillus gibsonii Alkaline Protease (BgAP) is a recently reported subtilisin protease exhibiting...
read more >>
Review: To get what we aim for - progress in diversity generation methods
5 June 2013
Ruff AJ, Dennig A, Schwaneberg
FEBS J., 280 (2013), 2961-2978
Protein re-engineering by directed evolution has become a standard approach for tailoring enzymes...
read more >>
Reengineered glucose oxidase for amperometric glucose determination in diabetes analytics
20 June 2013
Arango Gutierrez E, Mundhada H
Biosensors and Bioelectronics
Glucose oxidase is an oxidoreductase exhibiting a high β-d-glucose specificity and high stability...
read more >>

History

in
History

It all started with an idea of Prof. Dr. Ulrich Schwaneberg about developing a true alternative to common error-prone PCR. Over several years, the idea was shaped and finally named SeSaM - Sequence Saturation Mutagenesis. The technology was refined and continuously improved from its birth in 2004 until October 2008, when SeSaM-Biotech was founded as a spin-off of Jacobs Bremen University.

In 2012, SeSaM-Biotech moved to its new facilities in Aachen and on October 8 in 2013, we celebrated the 5-Year-Anniversary of SeSaM-Biotech! Since we like birthdays, there will definitely be more.